Showing 261-270 of 334 grants
| Title | Institution | Researcher | Program | Duration | Total Award Amount |
|---|---|---|---|---|---|
| JDRF-IQVIA Adult T1D Detection | IQVIA, Inc. | Nadejda Leavitt | Cures | 01-October-2022 to 31-August-2025 | $953,780.00 |
| A smart Semiconductor based Continuous Diabetes Monitoring Platform | Integrated Medical Sensors Inc | Muhammad Mujeeb-U-Rahman | Improving Lives | 01-June-2022 to 31-May-2025 | $500,000.00 |
| Exploiting SDF2L1 to protect against beta cell death and dysfunction in T1D | Indiana Biosciences Research Institute | Michael Kalwat | Cures | 01-December-2024 to 30-November-2027 | $748,169.00 |
| Genome-scale CRISPR screens identify ER export cargo proteins as mediators for β-cell stress response and antigen presentation | Indiana Biosciences Research Institute | Isabela Lovizutto Iessi Longo | Cures | 01-March-2023 to 28-February-2026 | $135,307.11 |
| ROLE OF ZBED3 IN BETA CELL STRESS RESPONSE AND VULNERABILITY AGAINST AUTOIMMUNITY | Indiana Biosciences Research Institute | Erica Cai | Cures | 01-March-2023 to 29-February-2028 | $999,737.71 |
| Targeting ER cargo proteins for beta cell protection against cellular stress and autoimmunity | Indiana Biosciences Research Institute | Erica Cai | Cures | 01-September-2023 to 31-August-2026 | $499,934.12 |
| Mitigating Diabetic Ketoacidosis Risk in Adjunctive Therapy (MDKARAT) | Illinois Institute of Technology | Mudassir Rashid | Improving Lives | 01-April-2022 to 31-March-2025 | $255,709.80 |
| Cardiotoxic Circulating Extracellular Vesicles: New Drivers of Type 1 Diabetes-induced Cardiomyopathy | Icahn School of Medicine at Mount Sinai | Susmita Sahoo | Improving Lives | 01-April-2025 to 31-March-2026 | $199,998.24 |
| Protective Genetic and Pharmacological Interventions to Prevent Cytokine and Autoimmune-based Destruction of β cells. | Icahn School of Medicine at Mount Sinai | Romina Bevacqua | Cures | 01-April-2025 to 31-March-2027 | $559,996.54 |
| Enhancing Functional Maturation of Stem Cell-Derived Beta Cells Using Harmine for Improved Diabetes Therapy | Icahn School of Medicine at Mount Sinai | Peng Wang | Cures | 01-July-2025 to 30-June-2026 | $305,000.00 |